The Society of Toxicology has established 27 Specialty Sections that may propose sessions for the Annual Meeting, exchange information via newsletters, present awards, and participate in other scientific activities.
You must be an SOT Member to join a Specialty Section.
Join a Component Group Announcement
Interested in starting a new Specialty Section? Learn How
Specialty Sections Awards Listing
Global Initiative Matching Funds Guidelines
SOT Funding Available for Webinars
SOT Specialty Section Leaders
Specialty Section FAQ
Graduate Student Leadership Committee
The Biological Modeling Specialty Section (BMSS) has as its objectives to provide members with a focused venue for networking to develop and conduct programs and educational activities that emphasize the latest developments in biological modeling and to apply these to improving the risk assessment process. If you have any questions, or other feedback about the activities of the specialty section, please contact any of the Specialty Section Officers.
The objective of the Biotechnology Specialty Section (BTSS) is to provide a forum focused on addressing the key issues in the rapidly growing biotechnology field. Biotechnology has been defined as, “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use.” In toxicology, biotechnology has been used most abundantly in the context of biotechnology-derived macromolecules developed to treat disease; this term, however, also applies to several other modalities including genetically modified organics, biodegradable plastics, and biofuels. Research and development in biotechnology has already had a substantial effect on toxicology, and impacts biopharmaceuticals, diagnostics, food, agriculture, environmental waste management, and industrial application. Due to the complex and diverse nature of applications of biotechnology products, the biotechnology landscape will continue to evolve and pose novel challenges in toxicology. The BTSS will facilitate education and broad discussion of key issues in biotechnology, such as translational pharmacology and toxicology, biomarkers, mechanisms of toxicity, manufacturing processes, safety strategies, and overall risk evaluation of these entities.
The Carcinogenesis Specialty Section (CSS) is a subgroup of the Society of Toxicology membership that serves as a focal point for interaction of members interested in carcinogenesis. Section members have expertise and/or responsibilities in molecular mechanisms of carcinogenesis, genetic toxicology, testing strategies for carcinogens, chemoprevention and cancer risk assessment. The Section sponsors symposia, workshops and Section meetings at the Annual SOT meetings to provide opportunities for discussion of the latest developments in carcinogenesis. In addition, the Section sponsors Graduate Student Awards for meritorious research in carcinogenesis that is presented by predoctoral students at the Annual SOT meeting. The awards consist of cash prizes and recognition plaques. Elected officials consist of the President, Vice President, Vice President-elect, 2 Councilors and the Secretary/Treasurer.
The objectives of the Cardiovascular Toxicology Specialty Section (CVTSS) are several-fold. First, the CVTSS will serve to unite cardiovascular toxicologists from academia, government, industry, and the private sector. The CVTSS is committed to the promotion of scientific endeavors that identify, prevent and/or ameliorate cardiovascular toxicities. The CVTSS will actively participate in the greater field of toxicology (at the local, national and international levels) through the development of scientific programs, position statements, and outreach activities. Of equal importance, and inherent to each of these objectives is the facilitation of graduate education/training and the recruitment of new cardiovascular scientists.
The CVTSS will meet regularly at the SOT Annual Meeting. At this meeting, the CVTSS will elect officials and generate committees to achieve our objectives.
The Clinical and Translational Toxicology Specialty Section (CTTSS) provides a forum within the Society of Toxicology where members interested in the impact of pharmaceuticals, chemicals, plants, fungi, toxic terrestrial and marine animals on human health, can share state-of-the-art knowledge and propose new approaches for the treatment of these exposures, based on an understanding of their mechanisms of toxicity.
The CTTSS is committed to improving the management of human poisoning by using a translational approach that links molecular mechanisms to rational therapy and then stimulates clinicians to make novel observations about the nature of poisoning, which in turn will lead to further molecular or cellular studies. In addition, the CTTSS will stimulate discussion on the optimal regimens for treatment based on a detailed understanding of the toxicokinetics and toxicodynamics of the agent involved and the pharmacology and adverse effects of the proposed treatment.
The CTTSS provides a unique nexus at Society of Toxicology meetings for presentations and discussions on human toxicology. The Specialty Section will also strive to assist the Society in giving voice to those issues in human toxicology that are deemed to deserve greater recognition and attention among the collective membership and beyond.
The objectives of the Comparative and Veterinary Specialty Section (CVSS) are to: 1) promote the diverse application of veterinary toxicology, i.e., whole animal systems, comparative and clinical toxicology, animal models, and disease, nutrition and other physiological/confounding factors that can affect toxic endpoints; 2) serve as the focal point for interaction of members of the Society of Toxicology who are interested in veterinary toxicology; 3) conduct programs and educational activities which emphasize current developments and issues in veterinary toxicology; 4) relate those developments to the activities of the Society of Toxicology to stimulate interest and growth in veterinary toxicology as it relates to the general science of toxicology; 5) act as a resource to the Society in the area of veterinary toxicology. The CVSS offers a Graduate Student/Trainee Award for Outstanding Student Presentation at the SOT Annual Meeting.
The objectives of the Dermal Toxicology Specialty Section (DTSS) are to provide a forum for the interaction of individuals involved in risk assessment, pharmacokinetics, dermal penetration/absorption, hypersensitivity and dermal toxicity, regulatory issues, basic skin biology and other professionals working in the field of dermal research.
The Drug Discovery Toxicology Specialty Section (DDTSS) is designed to provide a forum for promoting the broad acceptance and understanding of new technologies and models that impact predictive toxicology. Growth of the toxicology skill set in the pharmaceutical industry has been driven largely by the need for more efficient drug discovery and by the realization that over 30 percent of molecules in development fail because of toxicity and side effects. DDTSS is a subspecialty created to fulfill the growing need for generating higher throughput, integrative, and predictive toxicological information, in an effort to reduce the attrition of drug candidates at later stages of development. Such efforts include in silico assessments, in vitro predictive tools, and other technologies such as genomics, proteomics, and metabonomics that may be used alone or as an integrated approach to support drug safety assessment. This specialty section seeks to foster discussion and guidance around appropriate current applications of such tools that could ultimately replace or refine traditional costly and time-consuming animal-based toxicology models. This specialty section will also identify gaps necessitating further investments in methods development.
The Ethical, Legal, and Social Issues (ELSI) Specialty Section provides a forum in which to discuss the ethical implications of results from our science as well as the resulting legal and social implications. In addition, this specialty section can serve as a forum for discussing issues related to research integrity and the conduct of research with animals and humans. The Ethical, Legal, and Social Issues Specialty Section will be of interest to toxicologists concerned about the broader impact of our research on bioethical and societal decision-making as well as the conduct and application of toxicology based research.
The Food Safety Specialty Section (FSSS) is a specialty group within the Society of Toxicology; it was formed in March 1993 to provide a forum for the interaction of toxicologists and other professionals involved in food safety. The purpose of this specialty section is to provide a vehicle where state-of-art research involving food safety and regulations can be communicated and to serve as a scientific resource for critical issues involving food safety.
The Immunotoxicology Specialty Section (ImToxSS) is a branch of the Society of Toxicology whose members include scientists with training in immunology, toxicology, and risk assessment. Our purpose is to promote immunotoxicology as a discipline by: (1) increasing our understanding of the impact that xenobiotics have on the immune system (2) advocating research into the mechanisms of immunomodulation, and (3) encourage the development of new methods and techniques to improve risk assessment. At the national meeting, the Section sponsors symposia, continuing education courses, workshops, and roundtable discussions. Annual meetings are held at the national meeting to discuss specialty section business and program topics for the following year. Pre- and postdoctoral students are encouraged to participate in the scientific program at the SOT Annual Meeting by presentation of an award for best poster session in the field of immunotoxicology. Student input into the Section is also encouraged, and facilitated by an appointed Student Representative that attends Section Officer’s meetings as a full voting member.
The In Vitro and Alternative Methods Specialty Section is a specialty group within the Society of Toxicology whose members have expertise in the application of in vitro techniques to problems of cellular toxicity, with a special emphasis on product safety evaluation. The interests of this Specialty Section include studies of the basic cellular processes involved in the induction of adverse outcomes of specific organs and the whole animal and the development of simple to complex cellular and subcellular systems to predict toxicity in vivo and for risk assessment purposes. Other significant topics of interest include in vitro test validation and all aspects of test development and acceptance for individual or regulatory purposes. The Section holds regular meetings at the SOT Annual Meetings to discuss topics of interest to the membership. In addition, the Section sponsors three student awards for poster on subjects related to in vitro toxicology, and continuing education courses and symposia at annual meetings. Elected officials consist of the President, Vice President, Vice President-elect, Councilors, and the Secretary/Treasurer.
The Inhalation and Respiratory Specialty Section (IRSS) provides a focus for members of the Society of Toxicology dealing with the impact of airborne chemicals and particles on the body. Issues of interest to IRSS include indoor and outdoor air pollution, occupational exposure to airborne contaminants, therapeutic drug delivery by inhalation, deposition and pharmacokinetics of agents delivered by the inhalation route, and interactions between inhaled materials and infectious allergic stimuli. The Section meets regularly at the SOT Annual Meeting to promote a better understanding of inhalation toxicology, to recognize students and colleagues for notable contributions to inhalation research, and to address issues of importance to this field. The Section sponsors travel awards for outstanding students, and recognition awards for new investigators and those with outstanding career achievements. Committees within the Section meet regularly to write issue papers and discuss topics for Symposia, Workshops, and Continuing Education Course. Elected officials consist of a President, Vice President, Vice President-elect, two Councilors, and a Secretary/Treasurer.
The Mechanisms Specialty Section represents a diverse group of members of the Society of Toxicology who have in common interests and expertise in elucidating the cellular, biochemical, and molecular mechanisms of action of toxic substances. The Mechanisms Specialty Section provides a focal point for interaction of members of the Society of Toxicology interested in mechanisms of action of toxic substances, fostering the development and dissemination of new advances in mechanistic research in toxicology. The Section membership develops and sponsors state-of-the-art symposia, workshops and Continuing Education courses at the Annual Meeting of the Society of Toxicology. In addition, the Section sponsors a Graduate Student Awards program for student members of the section, with awards made annually at the SOT meeting. Elected officials of the Specialty Section include the President, Vice President, Vice President-elect, Secretary/Treasurer, and two Councilors. A newsletter is published three times a year and distributed to all.
The Medical Device and Combination Product Specialty Section (MDCPSS) is a new SOT specialty section launched in September 2009. The purpose of the Medical Device Specialty Section is to provide an international forum where government, industry, consulting, and academic toxicologists can share state-of-the-art knowledge and develop new approaches for the evaluation of medical devices. The objectives for the MDCPSS are: 1) Provide an international focus group for toxicologists working in the area of medical devices and combination products including a device component; 2) Promote the development of new experimental methods for the evaluation of medical devices; 3) Sponsor scientific and educational programs that emphasize current developments and issues in the toxicological evaluation of medical devices; 4) Promote proactive communication and interactions among toxicologists in government regulatory agencies, regulated industry, and academia regarding current issues in medical device toxicology. Specific areas of interest include: plastics, metals, ceramics, materials of biologic origin, and validation of new/alternative toxicology assays for medical devices; and 5) Stimulate interest in medical device safety as a career path for new toxicologists.
The Metals Specialty Section is a subgroup of the Society of Toxicology, the membership of which has expertise in all aspects of metal toxicology. This includes mechanisms of action, analytical procedures, regulatory issues, assessment of target organ toxicity, etc. The Section holds regular meetings at the Annual SOT meetings to discuss topics of interest to the membership. In addition, the Section sponsors awards for students who have outstanding presentations at the national meeting, and sponsors continuing education courses and symposia at SOT Annual Meetings. Elected officials consist of the President, Vice-President, Vice President-elect, two Councilors and the Secretary/Treasurer.
The Mixtures Specialty Section was approved by the Society of Toxicology and inaugurated at the 2006 SOT Annual Meeting in San Diego, California. An organizational committee representing academia, government, industry, and the private sector were responsible for its establishment. The Mixtures Specialty Section supports the advancement of science-based safety assessment; facilitates the ability for government, industry, and academia to work together; and encourages funding for toxicology-related research from private and federal agencies.
The Molecular and Systems Biology Specialty Section (MBSS) is an organization integrating members of the Society that are using or interested in applying the varied approaches of molecular biology in their research programs. Molecular toxicology has become an increasingly important focus of the academic, industrial, and regulatory arena. Tools ranging from transgenic technologies to reporter gene assays in single cells are providing exciting opportunities for studying the effects of toxic agents at their molecular targets, and for
understanding the regulation and mechanisms of these interactions.
The Molecular and Systems Biology Specialty Section is extremely active in organizing continuing education and symposia sessions for the
national SOT meetings and welcomes continuing as well as new members from the Society at large.
The objective of the Nanotoxicology Specialty Section is to serve as the focal point for the interaction of members of the Society of Toxicology interested in the science and toxicology of nanoscale materials, the responsible development of safe nanomaterials, and the application of nanotechnology to toxicological and environmental health problems. This will be achieved through the conduct of scientific programs and educational activities that address current developments and key issues in nanoscale science and toxicology.
The Neurotoxicology Specialty Section consists of members of the Society of Toxicology who are interested in the adverse effects of chemical, biological, or physical agents on the structure and function of the nervous system. Neurotoxicology Specialty Section members have research, regulatory, and/or industrial interests in the field of neurotoxicology as it relates to environmental chemicals and pharmaceuticals. This specialty section conducts regular meetings at the Annual SOT Meeting to promote exchange of information among neurotoxicologists. The Neurotoxicology Specialty Section elects officers, plans and sponsors workshops and symposia, and fosters the discussion of research topics of mutual interest to members. The Section also sponsors a number of undergraduate and graduate level research awards for students who present outstanding research at the national meeting. Elected officials include the President, Vice President, Vice President-elect, Secretary/Treasurer, two Councilors and a Student Representative.
The Occupational and Public Health Specialty Section (OPHSS) resulted from the merger of the Occupational Health and the Epidemiology Specialty Sections. The goal of the OPHSS is to advance the integration of exposure, toxicological and epidemiological principles and research approaches in addressing occupational, environmentally-related, and public health issues. The OPHSS seeks to achieve this goal by: (1) identifying and encouraging integrative research to further the understanding of the impact of exposure to chemicals, pollutants, and pharmaceutical drugs on the general and susceptible populations, and, in turn, (2) better informing regulatory decisions and actions that impact both individual and population health, (3) identifying and promoting the continual
development and application of emerging methods, tools, and models, and (4) sponsor and support activities to attract the next generation of scientists to occupational and environmental public health.
The Ocular Toxicology Specialty Section (OTSS) was formed in 2008 to provide a forum for the interaction of toxicologists and other professionals involved in ocular toxicity/toxicology studies, to advocate the development of sound science-based guidelines for ocular assessment of therapeutics and update, as needed, guidelines for ocular irritancy assessment, to organize educational programs which emphasize new developments and issues in ocular toxicology and to provide a liaison with other professional organizations such as the International Society of Ocular Toxicology and the Association for Research in Vision and Ophthalmology. The OTSS plans to offer educational sessions in the field of the eye at annual SOT meetings.
The Regulatory and Safety Evaluation Specialty Section (RSESS) brings together toxicologists concerned with scientific and regulatory issues related to evaluation of the safety of new and existing commercial products and environmental agents. Meetings provide an opportunity for informal discussion with toxicologists working or interested in these areas. Our scientific program at the SOT Annual Meeting, as well as our periodic newsletters, generally highlight issues of current regulatory importance or new scientific
developments that impact toxicological safety assessment. A popular feature of our Annual Meeting is the “Great Debate” that features discussion of a highlighted topic by two or more highly regarded scientists in the field. The extensive interest in the areas we represent has made us the largest of the 27 specialty sections within the SOT.
The Reproductive and Developmental Specialty Section (RDTSS) is a subgroup of the Society of Toxicology membership whose members have expertise and/or responsibility for assessment of toxicology of the reproductive system or development of offspring. Included are all areas of male and female reproductions, developmental biology, teratology, and developmental and reproductive risk assessment. The Section holds regular meetings at the Annual SOT meetings to discuss topics of interest to the membership. In addition, the Section sponsors travel awards for students who have done outstanding work at the national meeting, and sponsors continuing education courses and symposia at annual meetings. Elected officials consist of the President, Vice President, Vice President-elect, two Councilors, and the Secretary/Treasurer.
The Risk Assessment Specialty Section (RASS) of the Society of Toxicology is one of the largest Specialty Sections in the SOT. Our membership consists of approximately equal representation from academics, government, industry, and the consulting world.
The Stem Cells Specialty Section (SCSS) is a subgroup of the Society of Toxicology membership that provides a forum for SOT members interested in stem cells and stem cell toxicology. Section members will have expertise in all types of stem cell models including embryonic, fetal, progenitor, induced pluripotent, mesenchymal, and immortalized stem cell lines. It will be comprised of academic, government, industry, clinical, and preclinical researchers in order to relate the developments in stem cells research to the activities of SOT to stimulate interest and growth in stem cells as it relates to the general science of toxicology. At the SOT Annual Meetings, the Section will sponsor continuing education courses and symposia as well as awards for Students and Postdoctoral Scholars. Elected officials will consist of the President, Vice President, Vice President-elect, three Councilors and the Secretary/Treasurer. There will also be Student and Postdoctoral Representatives.
The Toxicologic and Exploratory Pathology Specialty Section (TEPSS) formed with the goals of establishing scientific and educational programs dealing with current advances and policies regarding experimental pathology and to guide discussions regarding the application of these considerations to regulatory policy and risk assessment practices. Please contact officers or members for more information and/or to become a member
SOT does not review the Specialty Section websites for accuracy.